发明名称 Integrated insulin delivery system with continuous glucose sensor
摘要 Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
申请公布号 US9572936(B2) 申请公布日期 2017.02.21
申请号 US201314063790 申请日期 2013.10.25
申请人 DexCom, Inc. 发明人 Dobbles John Michael;Kamath Apurv Ullas;Mahalingam Aarthi;Brauker James H.
分类号 A61M5/172;A61B5/145;A61M5/142;G06F19/00;A61B5/00;A61M5/00;A61M5/178;A61M5/30;A61M11/00;A61M15/00 主分类号 A61M5/172
代理机构 Knobbe Martens Olson & Bear, LLP 代理人 Knobbe Martens Olson & Bear, LLP
主权项 1. An integrated system for monitoring a glucose concentration in a host and for delivering insulin to the host, the system comprising: a continuous glucose sensor, wherein the continuous glucose sensor is configured to substantially continuously measure a glucose concentration in a host, and to provide sensor data associated with the glucose concentration of the host; an electronics module comprising a bolus controller module configured to iteratively determine an insulin therapy instruction in response to an evaluation of a relationship of internally derived data and an engageable bolus constraint, wherein a relationship of internally derived data to the bolus constraint is evaluated in response to engagement of the bolus constraint, and wherein the bolus constraint comprises a maximum total insulin dose that can be delivered within a predefined time period in response to engagement of the bolus constraint; and an insulin delivery device configured to deliver insulin to the host, wherein the insulin delivery device is at least one of physically connected to a receiver and/or operably connected to a receiver, and wherein the insulin delivery device is configured to receive the insulin therapy instruction from the controller module.
地址 San Diego CA US